Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.
Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced its participation at the 29th International Annual Congress of the World Muscle...
– In a Phase 1 in healthy subjects, EDG-7500 was well-tolerated without meaningful changes in left ventricle ejection fraction (LVEF) – – CIRRUS-HCM single-dose trial of EDG-7500 in obstructive...
Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that members of the management team will hold a live webcast to discuss top-line...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 2.97 | 10.8039287013 | 27.49 | 30.586 | 26.11 | 898125 | 27.84676245 | CS |
| 4 | 13.34 | 77.9205607477 | 17.12 | 30.586 | 16.6 | 1818944 | 25.84762938 | CS |
| 12 | 8.53 | 38.8964888281 | 21.93 | 30.586 | 15.0473 | 1153616 | 22.35622782 | CS |
| 26 | 13.55 | 80.1301005322 | 16.91 | 30.586 | 14.9 | 930649 | 20.63749247 | CS |
| 52 | 23.35 | 328.41068917 | 7.11 | 30.586 | 5.12 | 835847 | 17.40916408 | CS |
| 156 | 12.28 | 67.5467546755 | 18.18 | 30.586 | 5.12 | 440121 | 15.07709808 | CS |
| 260 | 3.46 | 12.8148148148 | 27 | 40.49 | 5.12 | 396706 | 15.7011283 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
